Follow The Filings

CLX Clorox

Clorox earnings company data as of 1:57 PM ET 11/6

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2027 Q1 2 Nov EPS 0.99 1.39 Beat +40.4%
Rev $1.88B — —

Insider trades

Open-market buys and sales by CLX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CLX insider trades
  • $1.2M bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Pierre R Breber Director
    Buy
    $400K 4,000 shares at $100.06 +22% to stake
    Traded Nov 4 Filed Nov 5
    ↗
  2. Pierre R Breber Director
    Buy
    $429K 5,000 shares at $85.82 +39% to stake
    Traded May 5 Filed May 5
    ↗
  3. Pierre R Breber Director
    Buy
    $417K 4,000 shares at $104.13 +44% to stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 25 share withholdings for taxes and 17 stock grants.

SEC filings

Recent issuer filings from EDGAR, 9 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
DEFA14A DEFINITIVE ADDITIONAL MATERIALS Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Period Nov 18, 2026 Filing Doc
DEFA14A — Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 21 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf